MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Updates in Oncology

MedicineWorld.Org brings updates in the field of oncology that you cannot afford to miss. This page is meant to keep you updated on the latest events in the world of cancer. This updates in oncology covers the most relevent developments in the field of oncology and is expected to be a useful reference for physicians and patients.

MedicineWorld.Org: Updates in oncology



Breast cancer
  • Taxotere plus Herceptin improves survival (July 15, 2005)
  • Letrozole superior to Tamoxifen in adjuvant setting (June 16, 2005)
  • Herceptin Chemotherapy combination Improves survival in early stage breast cancer (April 25, 2005)
  • Avastin plus Chemotherapy Improves Survival for Breast Cancer (April 17, 2005)
  • Zometa reduces risk of skeletal complications (April 8, 2005)
  • New options in HER-2 positive breast cancer patients (March 30, 2005)
  • FDA approves Abraxane for the treatment of metastatic breast cancer (Jan 9, 2005)
  • Arimidex better than tamoxifen in the adjuvant treatment of breast cancer (Dec 8, 2004)


  • Lung cancer
  • Treatment options for advanced non-small cell lung cancer (June 12, 2005)
  • Clinical Trial of Iressa (Gefitinib) for Lung Cancer halted early (April 18, 2005)
  • Avastin in combination with chemotherapy improves survival in lung cancer (March 15, 2005)
  • Iressa fails to show survival advantage (Dec 18, 2004)
  • Tarceva approved for the tratment of NSCLC   Nov 19, 2004
  • FDA approves Alimta for the second line treatment of NSCLC
  • Important information on Alimta


  • Colorectal cancer
  • Test to determine camptosar dose   Dec 20, 2005
  • Oxaliplatin plus Avastin improves survival: ECOG study   Nov 29, 2004
  • Bevacizumab plus IFL improves survival in metastatic colorectal cancer (June 3, 2004)


  • Prostate cancer
  • Provenge significantly improves survival in advanced prostate cancer (Feb 17, 2005)


  • Carcinoid tumors
  • Slow Release Octreotide Increases survival in Carcinoid Syndrome (April 29, 2005)


  • Renal cell cancer
  • FDA apporves Sorafenib for metastatci renal cell cancer (Dec 20, 2005)
  • Sorafenib doubles survival in renal cell cancer (July 21, 2005)


  • Multiple myeloma
  • New alerts for Velcade (Bortezomib) (June 16, 2005)
  • Bortezomib (valcade) approved for second line treatment of myeloma (March 25, 2005)


  • CML
  • Drug interactions for imatinib (Feb 8, 2006)
  • New options for patients with CML (June 15, 2005)


  • Head and neck cancer
  • Erbitux plus Radiation effective in Head and Neck Cancer (June 9, 2005)


  • Pancreatic cancer
  • FDA Approves New Drug Combination For Pancreatic Cancer (November 8, 2005)
  • Capecitabine Gemzar Combination Improves Survival For Pancreatic Cancer (November 21, 2005)
  • Advances in pancreatic cancer (July 21, 2005)
  • Tarceva significantly improves survival in advanced pancreatic cancer (March 24, 2005)




  • MedicineWorl.Org: Updates in oncology

     
    BREAST CANCER MAIN PAGE
    Home| Breast cancer news | Common terms| Breast cancer treatment| Treatment by stage| Surgical treatment| Chemotherapy| Chemo drugs| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy| Radiation therapy| Monoclonal therapy| High dose chemotherapy| Recurrent breast cancer| Bisphosphonates | Pregnancy and breast cancer | Risk factors | Risk details | My risk | Comprehensive | Breast cancer statistics | African Americans | Ashkenazi | Asians | Hispanic | Men | Native Americans | Older women | Younger women | Pregnant women | BRCA
     


    Copyright statement
    The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.